Cerebral atherosclerosis is associated with cystic infarcts and microinfarcts but not alzheimer pathologic changes

Stroke

Volumn 44, Issue 10, 2013, Pages 2835-2841

  Zheng, Ling ^a   Vinters, Harry V ^b   Mack, Wendy J ^a   Zarow, Chris ^a   Ellis, William G ^c   Chui, Helena C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer; Atherosclerosis; Infarction; Microinfarct

Indexed keywords

APOLIPOPROTEIN E;

AGED; AGING; ALZHEIMER DISEASE; ARTERIOLOSCLEROSIS; ARTICLE; BRAIN ATHEROSCLEROSIS; BRAIN DAMAGE; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; LACUNAR STROKE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; REGISTER; SENILE PLAQUE; VASCULAR AMYLOIDOSIS; VASCULAR DISEASE;

ALZHEIMER; ATHEROSCLEROSIS; INFARCTION; MICROINFARCT;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; BRAIN INFARCTION; CEREBRAL AMYLOID ANGIOPATHY; FEMALE; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; MALE; REGISTRIES; STROKE, LACUNAR;

EID: 84888363533     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.001945     Document Type: Article

References (31)

1. Arvanitakis Z, Leurgans SE, Barnes LL, Bennett DA, Schneider JA. Microinfarct pathology, dementia, and cognitive systems. Stroke. 2011;42:722-727.
2. Launer LJ, Hughes TM, White LR. Microinfarcts, brain atrophy, and cognitive function: The Honolulu Asia Aging Study Autopsy Study. Ann Neurol. 2011;70:774-780.
3. Holtzman DM. Role of apoe/Abeta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy. J Mol Neurosci. 2001;17:147-155.
4. Beach TG, Wilson JR, Sue LI, Newell A, Poston M, Cisneros R, et al. Circle of Willis atherosclerosis: Association with Alzheimer's disease, neuritic plaques and neurofibrillary tangles. Acta Neuropathol. 2007;113:13-21.
5. Honig LS, Kukull W, Mayeux R. Atherosclerosis and AD: Analysis of data from the US National Alzheimer's Coordinating Center. Neurology. 2005;64:494-500.
6. Chui HC. Subcortical ischemic vascular dementia. Neurol Clin. 2007;25:717-40.
7. Jagust WJ, Zheng L, Harvey DJ, Mack WJ, Vinters HV, Weiner MW, et al. Neuropathological basis of magnetic resonance images in aging and dementia. Ann Neurol. 2008;63:72-80.
8. Chui HC, Zarow C, Mack WJ, Ellis WG, Zheng L, Jagust WJ, et al. Cognitive impact of subcortical vascular and Alzheimer's disease pathology. Ann Neurol. 2006;60:677-687.
9. Folstein MF, Folstein SE, McHugh PR. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
10. Mungas D, Reed BR, Jagust WJ, De Carli C, Mack WJ, Kramer JH, et al. Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease. Neurology. 2002;59:867-873.
11. Fein G, Di Sclafani V, Tanabe J, Cardenas V, Weiner MW, Jagust WJ, et al. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology. 2000;55:1626-1635.
12. Vinters HV, Ellis WG, Zarow C, Zaias BW, Jagust WJ, Mack WJ, et al. Neuropathologic substrates of ischemic vascular dementia. J Neuropathol Exp Neurol. 2000;59:931-945.
13. Vonsattel JP, Myers RH, Hedley-Whyte ET, Ropper AH, Bird ED, Richardson EP Jr. Cerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological study. Ann Neurol. 1991;30:637-649.
14. Greenberg SM, Vonsattel JP. Diagnosis of cerebral amyloid angiopathy. Sensitivity and specificity of cortical biopsy. Stroke. 1997;28:1418-1422.
15. Braak H, Braak E, Bohl J. Staging of Alzheimer-related cortical destruction. Eur Neurol. 1993;33:403-408.
16. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), Part II, Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991;41:479-486.
17. McKeith IG. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J Alzheimers Dis. 2006;9(suppl 3):417-423.
18. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47:1113-1124.
19. The National Institute on Aging, and Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer's disease. Neurobiol Aging. 1997;18(suppl 4):S1-S2.
20. Jung S, Zarow C, Mack WJ, Zheng L, Vinters HV, Ellis WG, et al. Preservation of neurons of the nucleus basalis in subcortical ischemic vascular disease. Arch Neurol. 2012;69:879-886.
21. Reed BR, Mungas DM, Kramer JH, Ellis W, Vinters HV, Zarow C, et al. Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease. Brain. 2007;130 (pt 3):731-739.
22. Allison PD. Logistic Regression Using the SAS System: Theory and Application. Cary, NC: SAS Institute Inc; 1999.
23. Soontornniyomkij V, Lynch MD, Mermash S, Pomakian J, Badkoobehi H, Clare R, et al. Cerebral microinfarcts associated with severe cerebral beta-amyloid angiopathy. Brain Pathol. 2010;20:459-467.
24. Chui HC, Zheng L, Reed BR, Vinters HV, Mack WJ. Vascular risk factors and Alzheimer's disease: Are these risk factors for plaques and tangles or for concomitant vascular pathology that increases the likelihood of dementia? An evidence-based review. Alzheimers Res Ther. 2012;3:36.
25. Dolan H, Crain B, Troncoso J, Resnick SM, Zonderman AB, Obrien RJ. Atherosclerosis, dementia, and Alzheimer disease in the Baltimore Longitudinal Study of Aging cohort. Ann Neurol. 2010;68:231-240.
26. Breteler MM. Vascular risk factors for Alzheimer's disease: An epidemiologic perspective. Neurobiol Aging. 2000;21:153-160.
27. Luchsinger JA, Reitz C, Honig LS, Tang MX, Shea S, Mayeux R. Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology. 2005;65:545-551.
28. Chui HC, Zheng L, Reed BR, Vinters HV, Mack WJ. Vascular risk factors and Alzheimer's disease: Are these risk factors for plaques and tangles or for concomitant vascular pathology that increases the likelihood of dementia? An evidence-based review. Alzheimers Res Ther. 2012;4:1.
29. Peila R, Rodriguez BL, Launer LJ; Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes. 2002;51:1256-1262.
30. Arvanitakis Z, Schneider JA, Wilson RS, Li Y, Arnold SE, Wang Z, et al. Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology. 2006;67:1960-1965.
31. Ahtiluoto S, Polvikoski T, Peltonen M, Solomon A, Tuomilehto J, Winblad B, et al. Diabetes, Alzheimer disease, and vascular dementia: A population-based neuropathologic study. Neurology. 2010;75:1195-1202.